Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales … – BNET
Wyeth Targeted "High Risk" Black Patients for Off-Label Kidney Drug Sales …
BNET Mr. Wasserman's representations directly contradict the FDA's Black Box warning, which states that “sirolimus in combination with cyclosporine or tacrolimus … |